RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Ammon, ID · +55 more sites
3 recruiting type 2 diabetes studies with a site in Ammon, ID.
Sponsor: AstraZeneca
Ammon, ID · +55 more sites
Sponsor: Eli Lilly and Company
Ammon, ID · +39 more sites
Sponsor: Eli Lilly and Company
Ammon, ID · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.